This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignees: Shanghai Cell Therapy Group Co., Ltd., Shanghai Cell Therapy Research Institute. Active years: 2024.
Company Filing History:
1 out of 2 
1 out of 1 Years Active: 2024
Title: Innovations in Immunotherapy: The Contributions of Inventor Jieying Xu
Introduction: Jieying Xu, based in Shanghai, China, is a notable inventor whose work has significantly advanced the field of immunotherapy. She holds a patent for a transgenic killer cell that efficiently and stably expresses antibodies, paving the way for new therapeutic approaches in treating various diseases.
Latest Patents: The patent granted to Jieying Xu is titled "Killer cell capable of efficiently and stably expressing antibody, and uses thereof." This innovative creation involves a transgenic killer cell with a genome that incorporates a coding sequence for a human Fc section antibody along with an expression cassette for either a chimeric antigen receptor or an inhibitory or agonistic antibody. It also includes inverted terminal repeat sequences from a transposon at both ends. Besides the patented cell, a pharmaceutical composition comprising this transgenic killer cell and its uses are also included in her patent documentation.
Career Highlights: Jieying Xu has made significant contributions during her career, particularly through her roles at renowned institutions such as the Shanghai Cell Therapy Research Institute and Shanghai Cell Therapy Group Co., Ltd. Her experience in these organizations has furthered her research and development efforts in cell therapies.
Collaborations: Throughout her professional journey, Jieying has collaborated with esteemed colleagues like Qijun Qian and Huajun Jin. These partnerships have enabled her to enhance her research capabilities and drive pivotal innovations in the field.
Conclusion: Jieying Xu is an inspiring inventor whose groundbreaking patent on transgenic killer cells represents a major step in immunotherapy. Her contributions in both research and collaborative ventures continue to play a crucial role in the ongoing evolution of therapeutic techniques aimed at combating diseases. As innovation in this realm progresses, her work will undoubtedly have a lasting impact on future treatments.